<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="16704">Uridine</z:chebi> 5'-<z:chebi fb="0" ids="15266,18036">triphosphate</z:chebi> (<z:chebi fb="6" ids="15713">UTP</z:chebi>) induced long-lasting contractions of isolated human brain arteries; contractions without decrement were observed for periods of up to 20-24 hours at which time the tissues were relaxed in a dose-dependent manner by <z:chebi fb="1" ids="28177">theophylline</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>In some vessels, rhythmic oscillations accompanied the prolonged elevation in tension </plain></SENT>
<SENT sid="2" pm="."><plain>In canine middle cerebral arteries, <z:chebi fb="6" ids="15713">UTP</z:chebi> produced dose related contractions within the dose range of 1.7 X 10(-6) to 1.7 X 10(-4) M; these responses were unaffected by methysergide 2.8 X 10(-7) M, phenoxybenzamine 2.9 X 10(-5) M or <z:chebi fb="0" ids="49662">indomethacin</z:chebi> 9.8 X 10(-6) M, suggesting that the <z:chebi fb="6" ids="15713">UTP</z:chebi> mechanism of action is probably independent of tryptaminergic or alpha adrenergic receptor activation, or of <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> biosynthesis </plain></SENT>
<SENT sid="3" pm="."><plain>The ability of <z:chebi fb="6" ids="15713">UTP</z:chebi> to produce prolonged contraction of cerebral vessels, thus, provides an in vitro preparation in which it is possible to study some of the basic mechanisms that are associated with <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
</text></document>